Australia's First Sovereign Thorium-228 Manufacturing Capability
Sector: Government • Location: Brisbane, Queensland, Australia
Source: InDaily Queensland
This project aims to establish Australia's first sovereign manufacturing capability for Thorium-228, a critical isotope used in next-generation targeted alpha therapies for cancer treatment. The project is led by AdvanCell and will create 79 new jobs, positioning Queensland as the only jurisdiction globally capable of producing Thorium-228 at a commercial scale.
- Status
- Closed
- Sector
- Government, Manufacturing (Industrial), Commercial
- Location
- Brisbane, Queensland, Australia
- Updated
- 22 Jul 2026
- Source
- InDaily Queensland
ConstructChat
Ask ConstructChat about Australia's First Sovereign Thorium-228 Manufacturing Capability
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | awarded |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | This project aims to establish Australia's first sovereign manufacturing capability for Thorium-228, a critical isotope used in next-generation targeted alpha therapies for cancer treatment. The project is led by AdvanCell and will create 79 new jobs, positioning Queensland as the only jurisdiction globally capable of producing Thorium-228 at a commercial scale. |
Original sector | Biomedical |
Budget |
Location
Country | Australia |
State | Queensland |
City | Brisbane |
Source
Source | InDaily Queensland |
URL |
More Details
Record type | Project |
Sector | Government, Manufacturing (Industrial), Commercial |
Article published date | 2026-05-13 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project